Malaria J

The most recent articles from: Malaria J November 2018

Malaria J · Nov 2018

Review

Tafenoquine and primaquine do not exhibit clinical neurologic signs associated with central nervous system lesions in the same manner as earlier 8-aminoquinolines.

Tafenoquine was recently approved for Plasmodium vivax radical cure (KRINTAFEL™) and malaria prevention (ARAKODA™). ⋯ Extrapolation of data from Rhesus monkeys to humans, and the available clinical data, suggest that tafenoquine also does not exhibit pamaquine, pentaquine or plasmocid-like clinical neurologic signs in humans.

keep going… or not…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.